Lipocine Inc.

NASDAQ: LPCN · Real-Time Price · USD
3.03
-0.01 (-0.33%)
At close: Aug 15, 2025, 3:59 PM
3.04
0.33%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lipocine Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
4.21M 3.67M 11.2M 7.92M 4.8M 4.71M -2.85M -3.07M 54.99K 554.99K 500K 16.59M 16.64M 16.14M 16.14M 54.99K n/a n/a
Cost of Revenue
2.18M 1.91M 1.9M 1.88M 1.87M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-3.41M -3.68M 3.85M 571.17K 2.93M 4.71M -2.85M -3.07M 54.99K 554.99K 500K 16.59M 16.64M 16.14M 16.14M 54.99K n/a n/a
Operating Income
-5.58M -6.47M -1.16M -5.29M -9.71M -10.37M -17.93M -17.9M -13.75M -13.33M -12.12M 3.23M 2.59M 3.13M 3.15M -14.44M -15.28M -16.51M
Interest Income
930.84K 1.04M 1.15M 1.21M 1.26M 1.33M 1.37M 1.36M 1.21M 901.47K 553.05K 278.33K 131.63K 79.1K 67.7K 48.18K 36.53K 26.36K
Pretax Income
-4.51M -5.37M 9.03K -4.05M -8.49M -8.97M -16.35M -16.3M -12.06M -11.14M -10.76M 4.1M 3.42M -753.9K -634.2K -17.77M -19M -18.56M
Net Income
-4.51M -5.37M 8.35K -4.06M -8.49M -8.97M -16.35M -16.3M -12.06M -11.14M -10.76M 4.1M 3.42M -754.1K -634.4K -17.77M -19M -18.56M
Selling & General & Admin
3.93M 4.55M 5M 5.26M 5.26M 5.19M 4.9M 4.66M 4.42M 4.11M 4.06M 4.22M 4.64M 5.04M 5.33M 6.6M 7.27M 7.7M
Research & Development
3.72M 5.59M 7.35M 7.95M 9.25M 9.89M 10.18M 10.17M 9.39M 9.78M 8.56M 9.14M 9.41M 7.97M 7.67M 7.89M 8.01M 8.82M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
7.65M 10.23M 12.48M 13.33M 14.55M 15.01M 14.87M 14.6M 13.32M 12.59M 11.8M 12.73M 13.26M 16.84M 16.64M 17.62M 18.75M 18.27M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 7.57K 7.57K 39.62K 84.46K 134.32K 203.29K 252.37K 291.83K 322.25K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
9.79M 10.23M 12.48M 13.33M 14.55M 15.01M 14.87M 14.6M 13.32M 12.59M 11.8M 12.73M 13.26M 16.84M 16.64M 17.62M 18.75M 18.27M
Income Tax Expense
200.00 681.00 681.00 1.24K 1.24K 755.00 755.00 681.00 681.00 681.00 681.00 200.00 200.00 200.00 200.00 200.00 200.00 200.00
Shares Outstanding (Basic)
5.35M 5.35M 5.34M 5.35M 5.34M 5.32M 5.29M 5.23M 5.19M 5.11M 5.16M 4.62M 4.31M 5.19M 5.19M 4.53M 5.07M 4.82M
Shares Outstanding (Diluted)
5.35M 5.35M 5.42M 5.35M 5.34M 5.36M 5.32M 5.29M 5.23M 5.23M 5.23M 5.25M 5.26M 5.19M 5.23M 5.23M 5.23M 4.82M
EPS (Basic)
-0.84 -1 0.01 -0.75 -1.61 -1.72 -3.14 -3.14 -2.39 -2.21 -2.12 0.74 0.67 -0.14 -0.17 -3.75 -4.29 -5.16
EPS (Diluted)
-0.85 -1.01 n/a -0.75 -1.6 -1.71 -3.11 -3.11 -2.31 -2.24 -2.17 0.69 0.47 -0.26 -0.29 -3.87 -4.38 -5.25
EBITDA
-5.52M -6.42M -1.11M -4.95M -9.36M -10.03M -17.59M -17.54M -12.91M -11.59M -10.72M 4.29M 3.66M -470.36K -302.94K -17.52M -18.71M -18.24M
EBIT
-5.58M -6.47M -1.16M -4.98M -9.4M -10.06M -17.62M -17.57M -12.93M -11.6M -10.73M 4.28M 3.66M -472.18K -303.03K -17.52M -18.71M -18.24M
Depreciation & Amortization
55.76K 48.16K 41.11K 33.54K 32.77K 32.35K 28.66K 23.24K 18.07K 12.55K 9.45K 6.97K 5.28K 3.59K 2.76K 3.82K 3.73K 3.64K